Drug re-profiling strategy for drug development

Tohru Mizushima, Takushi Namba

Research output: Contribution to journalArticle

Abstract

As a new strategy for drug discovery and development, we propose here the establishment of drug re-profiling strategy. In this strategy, the actions of existing medicines, whose safety and pharmacokinetic effects in humans have been confirmed already, are examined comprehensively at the molecular level and the results are used for the development of new medicines. For example, identification of the mechanisms underlying the side effects of medicines enables us to develop safer drugs. The results can also be used for developing existing drugs for use as medicines in treatment of other diseases. Promoting this research strategy could provide breakthroughs in drug discovery and development by pharmaceutical companies.

Original languageEnglish
Pages (from-to)106-112
Number of pages7
JournalDrug Delivery System
Volume26
Issue number2
DOIs
Publication statusPublished - 2011
Externally publishedYes

Fingerprint

Drug Discovery
Pharmaceutical Preparations
Pharmacokinetics
Safety
Research

Keywords

  • Drug discovery and development
  • Drug re-profiling
  • Existing medicines
  • Pharmaceutical company
  • Safety

ASJC Scopus subject areas

  • Pharmaceutical Science

Cite this

Drug re-profiling strategy for drug development. / Mizushima, Tohru; Namba, Takushi.

In: Drug Delivery System, Vol. 26, No. 2, 2011, p. 106-112.

Research output: Contribution to journalArticle

Mizushima, Tohru ; Namba, Takushi. / Drug re-profiling strategy for drug development. In: Drug Delivery System. 2011 ; Vol. 26, No. 2. pp. 106-112.
@article{61fd8346046f42f6b6b381f5c29969fc,
title = "Drug re-profiling strategy for drug development",
abstract = "As a new strategy for drug discovery and development, we propose here the establishment of drug re-profiling strategy. In this strategy, the actions of existing medicines, whose safety and pharmacokinetic effects in humans have been confirmed already, are examined comprehensively at the molecular level and the results are used for the development of new medicines. For example, identification of the mechanisms underlying the side effects of medicines enables us to develop safer drugs. The results can also be used for developing existing drugs for use as medicines in treatment of other diseases. Promoting this research strategy could provide breakthroughs in drug discovery and development by pharmaceutical companies.",
keywords = "Drug discovery and development, Drug re-profiling, Existing medicines, Pharmaceutical company, Safety",
author = "Tohru Mizushima and Takushi Namba",
year = "2011",
doi = "10.2745/dds.26.106",
language = "English",
volume = "26",
pages = "106--112",
journal = "Drug Delivery System",
issn = "0913-5006",
publisher = "Japan Society of Drug Delivery System",
number = "2",

}

TY - JOUR

T1 - Drug re-profiling strategy for drug development

AU - Mizushima, Tohru

AU - Namba, Takushi

PY - 2011

Y1 - 2011

N2 - As a new strategy for drug discovery and development, we propose here the establishment of drug re-profiling strategy. In this strategy, the actions of existing medicines, whose safety and pharmacokinetic effects in humans have been confirmed already, are examined comprehensively at the molecular level and the results are used for the development of new medicines. For example, identification of the mechanisms underlying the side effects of medicines enables us to develop safer drugs. The results can also be used for developing existing drugs for use as medicines in treatment of other diseases. Promoting this research strategy could provide breakthroughs in drug discovery and development by pharmaceutical companies.

AB - As a new strategy for drug discovery and development, we propose here the establishment of drug re-profiling strategy. In this strategy, the actions of existing medicines, whose safety and pharmacokinetic effects in humans have been confirmed already, are examined comprehensively at the molecular level and the results are used for the development of new medicines. For example, identification of the mechanisms underlying the side effects of medicines enables us to develop safer drugs. The results can also be used for developing existing drugs for use as medicines in treatment of other diseases. Promoting this research strategy could provide breakthroughs in drug discovery and development by pharmaceutical companies.

KW - Drug discovery and development

KW - Drug re-profiling

KW - Existing medicines

KW - Pharmaceutical company

KW - Safety

UR - http://www.scopus.com/inward/record.url?scp=79960047855&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79960047855&partnerID=8YFLogxK

U2 - 10.2745/dds.26.106

DO - 10.2745/dds.26.106

M3 - Article

AN - SCOPUS:79960047855

VL - 26

SP - 106

EP - 112

JO - Drug Delivery System

JF - Drug Delivery System

SN - 0913-5006

IS - 2

ER -